Coronary artery disease (CAD) is one of the most common causes of death worldwide. It is responsible for one-third of deaths in people over 35 years old, with the percentage reaching close to 50% (according to some estimates) in western countries.

The existing treatment is medical, surgical or a combination of both depending on the extent, severity and clinical presentation of CAD & .There has been significant progress made in developing novel strategies for patients suffering from CAD and its associated complications. These strategies have ranged from drugs to robotic surgery to nanotechnology.

Related Articles


Article icon
The Role of Ivabradine and Trimetazidine in the New ESC HF Guidelines

Ivan Milinkovic, Giuseppe Rosano, Yury Lopatin,

Citation: Cardiac Failure Review, 2016;2(2):123–9

Managing Heart Failure Patients with Multivessel Disease

John Pepper,

Citation: Cardiac Failure Review 2015;1(2):118–22